Brain Tumor Reports
54

Volume 18 Number 1
January 2016


Home > Publications > Brain Tumor Reports > Volume 18, Year 2016 > Number 1, January*


CONTENTS



CENTRAL NERVOUS SYSTEM
GLIOMAS
GLIOBLASTOMA
GLIOMATOSIS CEREBRI
GLIOSARCOMA
MEDULLOBLASTOMA
PILOMYXOID ASTROCYTOMA





CENTRAL NERVOUS SYSTEM



DIAGNOSIS AND EVALUATION


Yang ZL, Zhang LJ.
PET/MRI of central nervous system: current status and future perspective.
Eur Radiol. 2016 Jan 15. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




TREATMENT


Egan G, Cervone KA, Philips PC, Belasco JB, Finlay JL, Gardner SL.
Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.
Bone Marrow Transplant. 2016 Apr;51(4):542-5. doi: 10.1038/bmt.2015.313. Epub 2016 Jan 4.
Source | Abstract | Full text | Similar articles





GLIOMAS



OVERALL MANAGEMENT


Wen PY, Reardon DA.
Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Nat Rev Neurol. 2016 Feb;12(2):69-70. doi: 10.1038/nrneurol.2015.242. Epub 2016 Jan 18.
Source | Abstract | Full text | Similar articles




PROGNOSIS AND OUTCOMES


Ampie L, Choy W, DiDomenico JD, Lamano JB, Williams CK, Kesavabhotla K, Mao Q, Bloch O.
Clinical attributes and surgical outcomes of angiocentric gliomas.
J Clin Neurosci. 2016 Jun;28:117-22. doi: 10.1016/j.jocn.2015.11.015. Epub 2016 Jan 8.
Source | Abstract | Full text | Similar articles




TREATMENT


Falsini B, Chiaretti A, Rizzo D, Piccardi M, Ruggiero A, Manni L, Soligo M, Dickmann A, Federici M, Salerni A, Timelli L, Guglielmi G, Lazzareschi I, Caldarelli M, Galli-Resta L, Colosimo C, Riccardi R.
Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.
Brain. 2016 Feb;139(Pt 2):404-14. doi: 10.1093/brain/awv366. Epub 2016 Jan 14.
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



CASE REPORTS


Ben Nsir A, Gdoura Y, Thai QA, Zhani Kassar A, Hattab N, Jemel H.
Intraventricular Glioblastomas.
World Neurosurg. 2016 Apr;88:126-31. doi: 10.1016/j.wneu.2015.12.079. Epub 2016 Jan 8.
Source | Abstract | Full text | Similar articles




CLASSIFICATION


Hinrichs BH, Newman S, Appin CL, Dunn W, Cooper L, Pauly R, Kowalski J, Rossi MR, Brat DJ.
Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
Acta Neuropathol Commun. 2016 Jan 13;4:4. doi: 10.1186/s40478-015-0270-7.
Source | Abstract | Full text | Similar articles




DIAGNOSIS AND EVALUATION


Chakraborty S, Priamo F, Boockvar JA.
Magnetic Resonance Imaging to Identify Glioblastoma Molecular Phenotypes.
Neurosurgery. 2016 Feb;78(2):N20-1. doi: 10.1227/01.neu.0000479895.10242.9d.
Source | Abstract | Full text | Similar articles




ETIOLOGY, PATHOGENESIS AND PATHOLOGY


Okamoto S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y, Muragaki Y.
Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas.
Brain Tumor Pathol. 2016 Apr;33(2):129-36. doi: 10.1007/s10014-016-0248-6. Epub 2016 Jan 29.
Source | Abstract | Full text | Similar articles




Taha MS, Abdalhamid BA, El-Badawy SA, Sorour YM, Almsned FM, Al-Abbadi MA.
Expression of cytomegalovirus in glioblastoma multiforme: Myth or reality?
Br J Neurosurg. 2016 Jun;30(3):307-12. doi: 10.3109/02688697.2015.1119241. Epub 2016 Jan 8.
Source | Abstract | Full text | Similar articles




OVERALL MANAGEMENT


Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C.
ESTRO-ACROP guideline "target delineation of glioblastomas".
Radiother Oncol. 2016 Jan;118(1):35-42. doi: 10.1016/j.radonc.2015.12.003. Epub 2016 Jan 6.
Source | Abstract | Full text | Similar articles




PROGNOSIS AND OUTCOMES


Happold C, Gorlia T, Chinot O, Gilbert MR, Nabors LB, Wick W, Pugh SL, Hegi M, Cloughesy T, Roth P, Reardon DA, Perry JR, Mehta MP, Stupp R, Weller M.
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
J Clin Oncol. 2016 Mar 1;34(7):731-9. doi: 10.1200/JCO.2015.63.6563. Epub 2016 Jan 19.
Source | Abstract | Full text | Similar articles




Louvel G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste PJ, Dam Hieu P, Faillot T, Litre F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes JR, Barat JL, Langlois O, Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J; Club de Neuro-Oncologie of Société Française deNeurochirurgie.
Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients.
Radiother Oncol. 2016 Jan;118(1):9-15. doi: 10.1016/j.radonc.2016.01.001. Epub 2016 Jan 11.
Source | Abstract | Full text | Similar articles




TREATMENT


Brehmer S, Guthier CV, Clausen S, Schneider F, Schulte DM, Benker M, Bludau F, Glatting G, Marx A, Schmiedek P, Hesser J, Wenz F, Giordano FA.
Combined stereotactic biopsy and stepping-source interstitial irradiation of unresectable glioblastoma multiforme.
J Neurosurg Sci. 2016 Jan 15. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Cirkel GA, Kerklaan BM, Vanhoutte F, der Aa AV, Lorenzon G, Namour F, Pujuguet P, Darquenne S, de Vos FY, Snijders TJ, Voest EE, Schellens JH, Lolkema MP.
A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies.
Invest New Drugs. 2016 Apr;34(2):184-92. doi: 10.1007/s10637-015-0320-9. Epub 2016 Jan 20.
Source | Abstract | Full text | Similar articles




Erdem-Eraslan L, van den Bent MJ, Hoogstrate Y, Naz-Khan H, Stubbs A, van der Spek P, Böttcher R, Gao Y, de Wit M, Taal W, Oosterkamp HM, Walenkamp A, Beerepoot LV, Hanse MC, Buter J, Honkoop AH, van der Holt B, Vernhout RM, Sillevis Smitt PA, Kros JM, French PJ.
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.
Cancer Res. 2016 Feb 1;76(3):525-34. doi: 10.1158/0008-5472.CAN-15-0776. Epub 2016 Jan 13.
Source | Abstract | Full text | Similar articles




Giordano FA, Wenz F, Petrecca K.
Rationale for intraoperative radiotherapy (IORT) in glioblastoma.
J Neurosurg Sci. 2016 Jan 29. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Montemurro N, Perrini P, Blanco MO, Vannozzi R.
Second surgery for recurrent glioblastoma: A concise overview of the current literature.
Clin Neurol Neurosurg. 2016 Mar;142:60-4. doi: 10.1016/j.clineuro.2016.01.010. Epub 2016 Jan 14.
Source | Abstract | Full text | Similar articles




Quick-Weller J, Lescher S, Forster MT, Konczalla J, Seifert V, Senft C.
Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Br J Neurosurg. 2016 Jun;30(3):313-7. doi: 10.3109/02688697.2015.1119242. Epub 2016 Jan 8.
Source | Abstract | Full text | Similar articles




Saran F, Chinot OL, Henriksson R, Mason W, Wick W, Cloughesy T, Dhar S, Pozzi E, Garcia J, Nishikawa R.
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy.
Neuro Oncol. 2016 Jul;18(7):991-1001. doi: 10.1093/neuonc/nov300. Epub 2016 Jan 24.
Source | Abstract | Full text | Similar articles




Sardi I.
Prolonged exposure to doxorubicin after radiotherapy in glioblastoma.
Future Oncol. 2016 Mar;12(5):581-3. doi: 10.2217/fon.15.354. Epub 2016 Jan 22.
Source | Abstract | Full text | Similar articles




Swanson KD, Lok E, Wong ET.
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma.
Curr Neurol Neurosci Rep. 2016 Jan;16(1):8. doi: 10.1007/s11910-015-0606-5.
Source | Abstract | Full text | Similar articles




Taunk NK, Moraes FY, Escorcia FE, Mendez LC, Beal K, Marta GN.
External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.
Expert Rev Anticancer Ther. 2016;16(3):347-58. doi: 10.1586/14737140.2016.1143364. Epub 2016 Feb 9.
Source | Abstract | Full text | Similar articles




Zussman BM, Engh JA.
Patterns of Care and Clinical Decision Making for Recurrent Glioblastoma Multiforme.
Neurosurgery. 2016 Feb;78(2):N12-4. doi: 10.1227/01.neu.0000479889.72124.20.
Source | Abstract | Full text | Similar articles





GLIOMATOSIS CEREBRI



CLASSIFICATION


Herrlinger U, Jones DT, Glas M, Hattingen E, Gramatzki D, Stuplich M, Felsberg J, Bähr O, Gielen GH, Simon M, Wiewrodt D, Schabet M, Hovestadt V, Capper D, Steinbach JP, von Deimling A, Lichter P, Pfister SM, Weller M, Reifenberger G.
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Acta Neuropathol. 2016 Feb;131(2):321-2. doi: 10.1007/s00401-015-1523-z. Epub 2016 Jan 7.
Source | Abstract | Full text | Similar articles




Herrlinger U, Jones DT, Glas M, Hattingen E, Gramatzki D, Stuplich M, Felsberg J, Bähr O, Gielen GH, Simon M, Wiewrodt D, Schabet M, Hovestadt V, Capper D, Steinbach JP, von Deimling A, Lichter P, Pfister SM, Weller M, Reifenberger G.
Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Acta Neuropathol. 2016 Feb;131(2):309-19. doi: 10.1007/s00401-015-1495-z. Epub 2015 Oct 22. Erratum in:
Acta Neuropathol. 2016 Feb;131(2):321-2.
Source | Abstract | Full text | Similar articles




ETIOLOGY, PATHOGENESIS AND PATHOLOGY


Broniscer A, Chamdine O, Hwang S, Lin T, Pounds S, Onar-Thomas A, Shurtleff S, Allen S, Gajjar A, Northcott P, Orr BA.
Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
Acta Neuropathol. 2016 Feb;131(2):299-307. doi: 10.1007/s00401-015-1532-y. Epub 2016 Jan 7.
Source | Abstract | Full text | Similar articles





GLIOSARCOMA



PROGNOSIS AND OUTCOMES


Zhang G, Huang S, Zhang J, Wu Z, Lin S, Wang Y.
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
J Neurooncol. 2016 Apr;127(2):355-62. doi: 10.1007/s11060-015-2046-0. Epub 2016 Jan 2.
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



TREATMENT


Bonney PA, Santucci JA, Maurer AJ, Sughrue ME, McNall-Knapp RY, Battiste JD.
Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases.
J Clin Neurosci. 2016 Apr;26:161-3. doi: 10.1016/j.jocn.2015.10.022. Epub 2016 Jan 14.
Source | Abstract | Full text | Similar articles




Massimino M, Spreafico F, Pignoli E, Gandola L.
Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Pediatr Blood Cancer. 2016 Jun;63(6):1123-4. doi: 10.1002/pbc.25901. Epub 2016 Jan 14.
Source | Abstract | Full text | Similar articles





PILOMYXOID ASTROCYTOMA



CASE REPORTS


Chen AS, Paldor I, Tsui AE, Yuen TI.
Pilomyxoid astrocytoma in the adult cerebellum.
J Clin Neurosci. 2016 May;27:170-3. doi: 10.1016/j.jocn.2015.11.008. Epub 2016 Jan 14.
Source | Abstract | Full text | Similar articles